Page 6,425«..1020..6,4246,4256,4266,427..6,4306,440..»

Experimental Stem Cell Therapy May Help Burn Victims

Posted: Published on October 1st, 2012

For more than 40 years, Lesley Kelly of Glasgow, Scotland, lived with third-degree burns that stretched over 60 percent of her body. Kelly was 2 years old when she fell into a bathtub filled with hot water that scorched most of the right side of her body. She lost full range of motion around many of her joints. "When you have bad scarring, the buildup is very thick and has no elasticity," said Kelly, 45, whose right elbow was most affected by the buildup of scar tissue. "The problem with thermal burn scarring [is that] it's hard to get the range of motion." Kelly underwent numerous reparative surgeries through the years, but the scar tissue continued to grow back. The procedures did not lessen the look of her scars. In 2011, Kelly underwent a new, experimental procedure that used stem cells from her own fat tissue to repair the buildup around her right elbow. Surgeons cleaned the scar buildup around the elbow and used liposuction to pull fat from off Kelly's waist. They separated the fat cells from the stem and regenerative cells, which were then injected into the wound on Kelly's arm. The procedure took less than two hours. … Continue reading

Comments Off on Experimental Stem Cell Therapy May Help Burn Victims

New Therapy May Help Burn Victims

Posted: Published on October 1st, 2012

Lesley Kelly, 45, underwent stem cell therapy to repair scar tissue buildup in her right arm. (Cytori Therapeutics, Inc.) By Lara Salahi, ABC News For more than 40 years, Lesley Kelly of Glasgow, Scotland, lived with third-degree burns that stretched over 60 percent of her body. Kelly was 2 years old when she fell into a bathtub filled with hot water that scorched most of the right side of her body. She lost full range of motion around many of her joints. "When you have bad scarring, the buildup is very thick and has no elasticity," said Kelly, 45, whose right elbow was most affected by the buildup of scar tissue. "The problem with thermal burn scarring [is that] it's hard to get the range of motion." Kelly underwent numerous reparative surgeries through the years, but the scar tissue continued to grow back. The procedures did not lessen the look of her scars. In 2011, Kelly underwent a new, experimental procedure that used stem cells from her own fat tissue to repair the buildup around her right elbow. Surgeons cleaned the scar buildup around the elbow and used liposuction to pull fat from off Kelly's waist. They separated the fat … Continue reading

Comments Off on New Therapy May Help Burn Victims

World Renowned Scientists and Advocates to Celebrate and Shine Light on Stem Cell Breakthroughs

Posted: Published on October 1st, 2012

IRVINE, CA--(Marketwire - Oct 1, 2012) - Oct. 3 marks International Stem Cell Awareness Day, a global celebration where leading scientists, researchers and supporters will acknowledge the scientific advances of stem cell research and its ability to potentially treat a variety of diseases and injuries in the 21st century. This dedicated community is committed to unlocking the potential of stem cells and has made significant strides since the discovery of a method to grow human stem cells less than 15 years ago. "This is a critical and historic time for stem cell research," said Peter Donovan, Ph.D., director, Sue & Bill Gross Stem Cell Research Center, UC Irvine. "We're literally on the brink of developing new treatments for some of the world's most devastating diseases and injuries. The act of simply raising awareness about this research is one of the best things people can do to help accelerate the process. This event is a great opportunity for everyone to help spread the word and build momentum through a timely mass effort." Scientists at UC Irvine and other research facilities around the globe continue to work diligently to develop therapies to treat life threatening and debilitating conditions such as Alzheimer's disease, … Continue reading

Comments Off on World Renowned Scientists and Advocates to Celebrate and Shine Light on Stem Cell Breakthroughs

Houston Stem Cell Summit Announces Extraordinary Lineup of Keynote Speakers

Posted: Published on October 1st, 2012

HOUSTON, Oct. 1, 2012 /PRNewswire/ --The Houston Stem Cell Summit will host an extraordinary lineup of keynote speakers who represent the most accomplished stem cell scientists, clinicians and entrepreneurs in the United States. Joining these distinguished speakers will be Governor of Texas, Rick Perry, consistent champion of adult stem cell therapies. (Logo: http://photos.prnewswire.com/prnh/20120831/NY66463LOGO ) The Houston Stem Cell Summit will be held October 26 27 in its namesake city and will highlight the latest therapeutic research regarding the use of adult stem and progenitor cell therapies. The Summit will also provide a forum for entrepreneurs to discuss their latest efforts to commercialize stem cell therapies, and to debate and discuss FDA and other legal and regulatory issues impacting stem cell research and commercialization. Opening Keynote Address October 26, 2012 Arnold I. Caplan, PhD, Professor of Biology and Professor of General Medical Sciences (Oncology) Case Western Reserve University Dr. Caplan has helped shape the direction and focus of adult stem cell research and commercialization. Virtually every adult stem cell company and literally tens of thousands of research papers are based on Dr. Caplan's original and ground breaking research. Professor Caplan is considered to be the "father" of the mesenchymal stem cell … Continue reading

Comments Off on Houston Stem Cell Summit Announces Extraordinary Lineup of Keynote Speakers

Medistem and Superview Biotechnology Co. Ltd. Initiate Collaboration on Therapeutics Development Using Antibody and …

Posted: Published on October 1st, 2012

SAN DIEGO--(BUSINESS WIRE)-- Medistem Inc (Pink Sheets:MEDS) announced today the initiation of a collaboration with Superview Biotechnology Co. Ltd, a subsidiary of Yinhuan Holding Co from Yixing, China. The joint work will be aimed at using proprietary stem cell lines developed by Medistem for screening of monoclonal antibodies for therapeutic activity in the area of regenerative medicine. As part of the collaboration, the two companies will evaluate various candidates jointly, as well as apply for grants and share research data. To date, the majority of stem cell companies are focusing on the stem cell itself being a product. By collaborating with Superview Biotechnology, we aim to assess the feasibility of developing antibodies that can modulate the activity of stem cells that already exist in the body, said Thomas Ichim, CEO of Medistem. This approach not only provides methods of activating stem cells but also allows for the development of stem cell adjuvant therapies that could be used to resurrect stem cell candidates that failed in clinical trials. Superview Biotechnology has developed proprietary methods of rapidly generating monoclonal antibodies to esoteric protein targets. Medistem has a history of success in the area of stem cells, being the only company to take … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Medistem and Superview Biotechnology Co. Ltd. Initiate Collaboration on Therapeutics Development Using Antibody and …

More News

Posted: Published on October 1st, 2012

The Food and Drug Administration is warning U.S. consumers that the vast majority of Internet pharmacies are fraudulent and likely are selling counterfeit drugs that could harm them. The agency on Friday launched a national campaign, called BeSafeRx, to alert the public to the danger, amid evidence that more people are shopping for their medicine online, looking for savings and convenience. Instead, they're likely to get fake drugs that are contaminated, are past their expiration date or contain no active ingredient, the wrong amount of active ingredient or even toxic substances such as arsenic and rat poison. They could sicken or kill people, cause them to develop a resistance to their real medicine, cause new side effects or trigger harmful interactions with other medications being taken. "Our goal is to increase awareness," FDA Commissioner Dr. Margaret Hamburg told The Associated Press, "not to scare people away from online pharmacies. We want them to use appropriate pharmacies." That means pharmacies that are located in the U.S., are licensed by the pharmacy board in the patient's state and have a licensed pharmacist available to answer questions. In addition, the pharmacy must require a valid doctor's prescription for the medicine. Online drugstores that … Continue reading

Posted in Internet Pharmacy | Comments Off on More News

Medistem and Superview Biotechnology Co. Ltd. Initiate Collaboration on Therapeutics Development Using Antibody and …

Posted: Published on October 1st, 2012

SAN DIEGO--(BUSINESS WIRE)-- Medistem Inc (Pink Sheets:MEDS) announced today the initiation of a collaboration with Superview Biotechnology Co. Ltd, a subsidiary of Yinhuan Holding Co from Yixing, China. The joint work will be aimed at using proprietary stem cell lines developed by Medistem for screening of monoclonal antibodies for therapeutic activity in the area of regenerative medicine. As part of the collaboration, the two companies will evaluate various candidates jointly, as well as apply for grants and share research data. To date, the majority of stem cell companies are focusing on the stem cell itself being a product. By collaborating with Superview Biotechnology, we aim to assess the feasibility of developing antibodies that can modulate the activity of stem cells that already exist in the body, said Thomas Ichim, CEO of Medistem. This approach not only provides methods of activating stem cells but also allows for the development of stem cell adjuvant therapies that could be used to resurrect stem cell candidates that failed in clinical trials. Superview Biotechnology has developed proprietary methods of rapidly generating monoclonal antibodies to esoteric protein targets. Medistem has a history of success in the area of stem cells, being the only company to take … Continue reading

Posted in Cell Medicine | Comments Off on Medistem and Superview Biotechnology Co. Ltd. Initiate Collaboration on Therapeutics Development Using Antibody and …

Penn State College of Medicine follows strict rules about cadavers

Posted: Published on October 1st, 2012

Key cards are needed to enter the area where cadavers are dissected and kept at Penn State College of Medicine. Cell phones arent allowed. A few years ago, a student at one New York medical school posted a photo on Facebook showing a student giving a thumbs up while posing with a cadaver, and a student at another posted a photo involving a brain. At the Derry Twp.-based medical school, no such ethical violations have occurred, according to Michelle Lazarus, an anatomy instructor. Lazarus is also the intermediary between the school and the Humanity Gifts Registry, which oversees bodies donated for medical research in Pennsylvania. Lazarus says the school has long taken a strong ethical approach to use of cadavers. For example, through a collaboration with the humanities department, first-year medical students probe their feelings about the cadavers in writing assignments. They also are responsible for conducting a public memorial service following completion of their work on cadavers. Lazarus says, We tell them all the time this is your first patient. We feel really grateful to people who donate, and to their families. Its really important to us. We dont just think of it as a lab, says Michelle Matzko, … Continue reading

Posted in Cell Medicine | Comments Off on Penn State College of Medicine follows strict rules about cadavers

Charges of writing fake prescriptions – Video

Posted: Published on October 1st, 2012

28-09-2012 18:18 Multi-state pill distribution scheme. More here: Charges of writing fake prescriptions - Video … Continue reading

Posted in Prescriptions | Comments Off on Charges of writing fake prescriptions – Video

Fosamax Lawsuit Damages Agreement Does Not Moot Merck’s Liability, Notes Rottenstein Law Group

Posted: Published on October 1st, 2012

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, stresses that a confidential agreement on damages between Merck and an ONJ victim does not moot a jurys verdict finding the company liable for the claimants injuries. New York, NY (PRWEB) October 01, 2012 Rochelle Rottenstein, principal of the Rottenstein Law Group, stresses that Ms. Boles, who, according to court documents, passed away in September 2011, had proved her case against the pharmaceutical giant. The jury found for Ms. Boles, Rottenstein notes. That jury awarded her $8 million in damages. The court, deeming that award to be excessive, gave the plaintiff the choice between a reduced award of $1.5 million and a new trial on damages. But Mercks wrongdoing and liability were proven as matters of fact and law. Boles chose a retrial on damages, which was scheduled for September 10, 2012, then adjourned to September 18, 2012, according to court documents. The parties had been submitting to Judge Keenan of the United States District Court of the Southern District of New York motions regarding the evidence to be presented at the new damages trial. Early this month, plaintiffs counsel made … Continue reading

Posted in Drug Side Effects | Comments Off on Fosamax Lawsuit Damages Agreement Does Not Moot Merck’s Liability, Notes Rottenstein Law Group

Page 6,425«..1020..6,4246,4256,4266,427..6,4306,440..»